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Abstract
Patients with pulmonary tuberculosis (TB) can be simultaneously infected with different strains of Mycobacterium tuberculosis (mixed infec-
tion). We investigated the prevalence and risk factors of mixed infection by Beijing and non-Beijing strains in pulmonary TB patients in
Taiwan. We developed a quantitative PCR method to simultaneously detect the presence of Beijing and non-Beijing strains. A total of
868 pretreatment samples (from 868 patients), including 563 sputum samples smear-positive for acid-fast bacilli and 305 liquid medium
samples culture-positive for mycobacteria, were tested. Medical records of patients with culture-conﬁrmed pulmonary TB were
reviewed. The detection limit of our quantitative PCR method was ﬁve copies of target sequences. With mycobacterial culture result as
the reference standard, the sensitivity and speciﬁcity of our quantitative PCR method were 95% and 98%, respectively. M. tuberculosis
strains were isolated in 466 samples, of which 231 (49.6%) were infected with a Beijing strain. Another 14 patients (3.0%) had mixed
infection, with the Beijing strain being the dominant strain in 13 (93%). Age <25 years with pulmonary cavities was associated with mixed
infection. In patients infected with non-Beijing strains, the bacterial load of non-Beijing strains was lower among those with mixed infec-
tion than among those without. Our quantitative PCR method was accurate in detecting Beijing and non-Beijing strains in smear-positive
sputum and culture-positive liquid medium samples. Mixed infection was present in pulmonary TB patients (3.0%), especially in those aged
<25 years with pulmonary cavities. Beijing strains seem to be more dominant than non-Beijing strains in patients with mixed infection.
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Introduction
It has been commonly thought that tuberculosis (TB) is
caused by a single strain of Mycobacterium tuberculosis [1,2].
However, studies have found that patients may be simulta-
neously infected with different strains (mixed infection) [3,4].
By amplifying and detecting DNA sequences of Beijing and
non-Beijing strains, a study in Cape Town showed that 19%
of all patients with TB were simultaneously infected with one
Beijing and one non-Beijing strain, and that this occurred
more frequently in retreatment cases (23%) [5]. Several
other genotypic approaches based on detecting genomic
regions speciﬁcally deleted in the Beijing strains have also
been utilized to identify Beijing strain and mixed infection in
clinical samples [6–8]. The presence of mixed infection can
lead to conﬂicting results of drug susceptibility testing if both
drug-susceptible and drug-resistant M. tuberculosis strains are
present [9–11]. Drug-resistant strains may not be detected
initially if susceptible strains are predominant, but may out-
number susceptible strains at a later point in time during
anti-TB treatment. Furthermore, it was observed that a
drug-susceptible strain re-emerged in patients with multi-
drug-resistant (MDR) TB treated with second-line anti-TB
drugs [12]. Therefore, undetected drug-resistant strains in
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the presence of drug-susceptible strains may result in unfa-
vourable treatment outcomes.
The prevalence and risk factors of mixed infection in tuber-
culous populations have rarely been investigated, mainly
because of technical difﬁculties. In Taipei, Taiwan, Beijing
strains account for 50% of the clinical isolates of M. tuberculosis
[13]. Therefore, the magnitude of mixed infection could be
investigated by simultaneous detection of one Beijing and one
non-Beijing strain. As the incidence of TB in Taipei is not as
high as that in the study sites of Cape Town, we thought that
mixed infection in TB is less frequent in Taipei, but hypothe-
sized that it was not undetectable. Therefore, we conducted a
study to investigate the prevalence and risk factors of simulta-
neous infection with Beijing and non-Beijing strains in patients
with pulmonary TB by using a real-time quantitative PCR
(Q-PCR) method. We report the results of this study.
Materials and Methods
Materials and protocols
This prospective study was conducted in a 700-bed medical
centre in northern Taiwan. Pretreatment sputum samples from
patients suspected of having TB that were either smear-posi-
tive for acid-fast bacilli or culture-positive for mycobacteria
were collected from July 2007 to December 2008 in the myco-
bacteriology laboratory, which is a regional reference labora-
tory whose quality is periodically assessed by the national
reference laboratory of the Taiwan Centers for Disease Con-
trol. Only one specimen was collected from each patient.
Mycobacteriological studies were performed as previously
described (see Data S1) [14,15]. For sputum samples that
were smear-positive for acid-fast bacilli, or culture-positive in
liquid medium, we immediately extracted genomic DNA [16]
and performed a PCR test with the Cobas Amplicor MTB sys-
tem (Roche Diagnostics Corporation, Indianapolis, IN, USA),
according to the manufacturer’s instructions. The results of
the PCR test were analysed with the Cobas Amplicor Ana-
lyzer (Roche Instrument Center AG, Rotkreuz, Switzerland).
Medical records of patients with pulmonary TB conﬁrmed
by both mycobacterial culture and Q-PCR test were
reviewed to obtain the demographic data, history of previous
TB, and chest radiographic ﬁndings.
Procedures of real-time Q-PCR
For each extracted genomic DNA, a Q-PCR test was also
performed to detect mixed infection, deﬁned as the simulta-
neous presence of a Beijing and a non-Beijing strain. If the
Q-PCR test revealed mixed infection, we then performed a
PCR with the same primer sets, and sequenced the ampli-
cons on an ABI Prism 3730 DNA sequencer with a BigDye
Terminator v3.1 Cycle Sequencing Ready Reaction Kit
(Applied Biosystems, Foster City, CA, USA) to conﬁrm their
presence.
Two primer sets and probes were designed to detect the
Beijing and non-Beijing strains of M. tuberculosis in the sam-
ples (see Fig. S1). The primer sequences for the Beijing
strains were complementary to the 3¢-end of the IS6110 ele-
ment and Rv2820. A positive Q-PCR signal indicated the
presence of an IS6110 insertion in Rv2820, which is unique
to the Beijing evolutionary lineage [17]. The primer
sequences for non-Beijing strains were complementary to
Rv2819. The standard curve for calculating the number of
copies of each DNA sequence in the sample was generated
with different concentrations of cloned plasmid containing
the target sequence (see Data S1).
To assess the reproducibility of Q-PCR, two independent
experiments were performed for each sample.
Minimizing laboratory cross-contamination
Several steps were applied to minimize the possibility of lab-
oratory cross-contamination. First, fewer than ﬁve samples
were processed at the same time. Second, acid-fast smears,
mycobacterial cultures, DNA extraction and Cobas Amplicor
MTB assays were performed in a biosafety level 2-plus labo-
ratory, and the Q-PCR was performed in a biosafety level 2
laboratory. For each Q-PCR reaction, DNA from two differ-
ent Beijing and two different non-Beijing strains, conﬁrmed
by spoligotyping [18], were used as positive controls, and
de-ionized water as negative control.
Statistical analysis
The reproducibility of the Q-PCR was evaluated by applying
Pearson’s correlation and t-test. Correlation between the
results of Cobas Amplicor and Q-PCR was evaluated by cal-
culating the kappa coefﬁcient. Because of the potentially non-
linear effect of age, the spline smoothing model was applied
to evaluate its impact on mixed infection. Multivariate logistic
regression analysis was used to identify risk factors of mixed
infection, and linear regression analysis to identify factors
inﬂuencing mycobacterial load (see Data S1). A two-sided p-
value <0.05 was considered to indicate signiﬁcance. All analy-
ses were performed with SAS software (Version 9.1.3; SAS
Institute, Cary, NC, USA).
Results
A total of 868 samples, including 563 smear-positive sputum
samples and 305 culture-positive liquid medium samples, col-
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lected from 868 patients were tested for the presence of
mixed infection. Of the 868 samples, 486 (56.0%) were cul-
ture-positive for M. tuberculosis and 382 were either culture-
negative (N = 261) or non-TB mycobacteria (N = 121).
Stability and reproducibility of the Q-PCR method
Fig. 1 shows that the correlation between the cycle threshold
number in the Q-PCR and the amount of either the Beijing
or non-Beijing DNA construct was good, despite the con-
comitant presence of the other DNA construct in a different
amount (R2 = 0.9997 and R2 = 0.9995, respectively).
The Pearson correlation between the results of the two
independent Q-PCR experiments for every sample was
0.999 for both Beijing and non-Beijing strains. The copy num-
bers calculated in two independent experiments for each
sample were not signiﬁcantly different for both strains (the
p-values of independent-sample t-tests were 0.906 and 0.921,
respectively).
Correlation between Q-PCR and Cobas Amplicor for the
detection of M. tuberculosis
Table 1 shows the comparison of Q-PCR with Cobas Ampli-
cor for the detection of M. tuberculosis in the 868 samples.
With culture result as the reference standard, the Q-PCR
yielded a false-negative result in 19 sputum samples and ﬁve
liquid medium samples. Four sputum samples and one liquid
medium sample had a false-positive Q-PCR result for Beijing
strains (1196, 678, 262, 31 and 61 copies, respectively).
Another sputum sample had a false-positive Q-PCR result
for non-Beijing strains (838 copies).
The results of Q-PCR correlated well with those of
Cobas Amplicor (the kappa coefﬁcient was 0.896 for sputum
samples, 0.946 for liquid medium samples, and 0.914 for
both). With culture result as the reference standard, the
Q-PCR method had an overall sensitivity and speciﬁcity
higher than 95% (Table 1).
Prevalence and risk factors for mixed infection
Among the 486 samples that were culture-positive for
M. tuberculosis, 466 were positive with the Q-PCR test. Of the
466 specimens, 292 (62.7%) were smear-positive sputum sam-
ples and 174 (35.8%) were culture-positive liquid medium sam-
ples (Table 2); 40 (8.5%) contained MDR M. tuberculosis
strains, 45 (9.7%) contained resistant but not MDR M. tubercu-
losis strains, and 381 (81.8%) contained susceptible strains; 231
(49.6%) contained Beijing strains, 221 (47.4%) contained non-
Beijing strains, and 14 (3.0%) showed mixed infection. The
mean age of the 466 patients was 58.3 years (range: 13.3–
95.6 years): 359 (77.0%) were men; 367 (78.8%) had smear-
positive pulmonary TB; 436 (93.6%) had never been treated
for TB; 144 (30.9%) had cavitary lesions on chest radiograph;
and 208 (44.6%) had bilateral lung parenchymal lesions.
Table 2 shows the proportion of patients with mixed
infection in the different subgroups. The spline smoothing
curve of the effect of age on risk of mixed infection after
FIG. 1. The good correlation between the cycle threshold (CT)
number in the quantitative PCR and the amount of the Beijing plas-
mid (left) or non-Beijing plasmid (right). Each data point and error
bar represent the average and 95% CI of the CT numbers when cor-
responding copies of one plasmid were mixed with seven different
copies (5, 50, 500, 5000, 50 000, 500 000, or 5 000 000) of the
other plasmid.
TABLE 1. Correlation between the results of two ampliﬁcation assays and mycobacterial culture for the detection of Myco-
bacterium tuberculosis
Assay Specimen (no.)
No. of samples
Sensitivity
(%)
Speciﬁcity
(%)
Culture-positive for
MTB (n = 486)
Culture-negative for
MTBa (n = 382)
Test + Test ) Test + Test )
Cobas Amplicor Sm+ sputum (563) 305 6 3 249 98.1 98.8
Cul+ medium (305) 177 2 0 126 98.9 100
Overall (868) 482 8 3 375 98.4 99.2
Q-PCR Sm+ sputum (563) 292 19 5 247 93.9 98.0
Cul+ medium (305) 174 5 1 125 97.2 99.2
Overall (868) 466 24 6 372 95.1 98.4
Cul, culture; MTB, Mycobacterium tuberculosis; Q-PCR, quantitative PCR; Sm, smear.
aCulture-negative or non-tuberculosis mycobacterium.
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controlling for sex and pulmonary cavities showed a positive
impact when age was <25 years or >70 years (see Fig. S2a).
Therefore, patients were classiﬁed into three groups
(Table 2).
Because of the presence of an interaction between age
and pulmonary cavity, an interaction variable was included in
the multivariate analysis for mixed infection (see Fig. S2b). In
the multivariate analysis, only age <25 years with the pres-
ence of pulmonary cavities was associated with mixed infec-
tion (p 0.006; OR 9.6; 95% CI 1.9–47.5).
Factors inﬂuencing bacterial load of Beijing and non-Beijing
strains
Among the 14 patients with mixed infection, the median age
was 54 years, and there was a male/female ratio of 1.3 (see
Table S1). The average bacterial loads of the Beijing and
non-Beijing strains were 1100 and 84 copy, respectively.
Beijing strains were the dominant strains in 13 (93%)
patients. Among them, ﬁve (36%) had underlying comorbidi-
ty, and two (14%) had MDR TB. Within 1 year, 13 (93%)
patients with mixed infection had been completely treated,
as compared with 392 (87%) of the 452 patients without
mixed infection (p 1.000 by Fisher’s exact test).
In patients infected with Beijing strains (n = 245, including
231 infected with Beijing strains only and 14 with mixed
infection), linear regression analysis revealed that the bacte-
rial load of non-Beijing strains had no inﬂuence on that of
the Beijing strain (Table 3). However in patients infected
with non-Beijing strains (n = 235, including 221 infected with
non-Beijing strains only and 14 with mixed infection), the
bacterial load of Beijing strains was negatively correlated with
that of non-Beijing strains. The presence of drug resistance
was associated with the bacterial load of either Beijing or
non-Beijing strain.
Discussion
The prevalence of mixed infection in TB patients is highly
variable in different studies, ranging from 2.1% to 54%
[3,5,12,19–26], with a trend showing that it parallels the local
TB incidence. However, these results may not be directly
comparable, owing to the limited number of patients (n = 9–
249), the heterogeneity in study designs (different colonies
from one isolate vs. serial isolates), and differences in meth-
odology. In our study, the prevalence of mixed infection in
culture-positive liquid medium samples from patients with
pulmonary TB in Taiwan was 4.6%, much less than that
(18.8%) in Cape Town [5], an area with a TB annual inci-
dence (251 per 100 000 population) about four-fold higher
than that in northern Taiwan (62 per 100 000 population)
[27]. In Shanghai, China, an area with a TB annual incidence
(38 per 100 000 population) less than that in Taiwan, the
prevalence of mixed infection was 5.6% [23].
In previous studies, clinical details of the patients with
mixed infection have usually been lacking. Only two have
reported that mixed infection is more frequently observed
among retreatment patients [5,23]. However, whether re-
TABLE 2. Proportion of patients with mixed infection in dif-
ferent subgroups
Characteristics
Total
no. (%)
No. (%) of
mixed
infection OR (95% CI)
Sample Liquid culture
medium
174 (37.3) 8 (4.6) 2.30 (0.78–6.74)
Sputum 292 (62.7) 6 (2.1)
Age (years) >70 150 (32.2) 5 (3.3) 0.31 (0.07–1.38)
25–70 286 (61.4) 6 (2.1) 0.19 (0.05–0.82)
<25 30 (6.4) 3 (10.0)
Sex Women 107 (23.0) 6 (5.6) 2.60 (0.88–7.69)
Men 359 (77.0) 8 (2.2)
Smear grading 3+ to 4+ 105 (22.5) 3 (2.9) 0.70 (0.15–3.20)
1+ to 2+ 262 (56.2) 7 (2.7) 0.65 (0.19–2.28)
Negative 99 (21.2) 5 (4.0)
Susceptibility MDR 40 (8.6) 2 (5.1) 1.82 (0.39–8.54)
Resistant but
not MDR
45 (9.7) 1 (2.2) 0.77 (0.10–6.08)
All susceptible 381 (81.7) 10 (2.6)
Extent on
CXR
Bilateral 208 (44.6) 8 (3.8) 1.68 (0.57–4.92)
Unilateral 258 (55.4) 6 (2.3)
Cavity(ies)
on CXR
Yes 144 (30.9) 8 (5.6) 3.10 (1.05–9.10)
No 322 (69.1) 6 (1.9)
TB relapse Yes 30 (6.4) 2 (6.7) 2.52 (0.54–11.83)
No 436 (93.6) 12 (2.8)
CXR, chest radiograph; MDR, multidrug-resistant; MGIT, TB, tuberculosis.
TABLE 3. Linear regression analysis for factors inﬂuencing the bacterial load in patients infected with Beijing or non-Beijing
strains
Dependent variable
Independent variable
Parameter
estimate
Standard
error t-value p-value
Variance
inﬂation
Log (copy no. of Beijing strain) in patients
infected with Beijing strain
Smear grading 0.32 0.05 )3.51 <0.001 1.017
Resistant but not MDR 0.55 0.24 2.84 0.017 1.022
Age >70 years with cavity )0.65 0.29 2.15 0.025 1.005
Log (copy no. of non-Beijing strain) in patients
infected with non-Beijing strain
Log (copy no. of Beijing strain) )0.26 0.07 )3.51 <0.001 1.001
Smear grading 0.16 0.06 2.84 0.005 1.000
Resistant but not MDR 0.45 0.21 2.15 0.032 1.000
MDR, multidrug-resistant.
Log represents the logarithm of the number in parentheses to base 10.
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treatment patients were relapse, defaulted or failure cases
was not further deﬁned. In our study, relapse of TB was not
associated with mixed infection, probably because the risk of
re-infection in Taipei is low or the prior course of anti-TB
treatment had eradicated all TB bacilli before new infection
occurred. The small number of patients in the study may
also contribute to the lack of association between relapse
and mixed infection.
The presence of cavities on the chest radiograph implies
high bacillary load [28], and has been reported to be associated
with a decreased interferon-c response [29]. Both conditions
imply advanced TB and a poor immune response [30]. The inci-
dence of TB is usually low in populations <25 years of age.
These young TB patients might have a genetic and immune pre-
disposition for mixed infection. Another possibility is that
young people have a higher risk of exposure to multiple
sources of TB infection, especially in crowded and closed
places such as internet cafe´s, pubs, or apartments.
The ﬁndings that Beijing strains were the very dominant
subpopulation in 93% of our patients with mixed infection,
and that the presence of a Beijing strain was signiﬁcantly
associated with a lower bacterial load of non-Beijing strains
in patients infected with non-Beijing strains, suggest that Beij-
ing strains may have a survival advantage [31]. However, fur-
ther studies on ﬁtness are necessary to conﬁrm our ﬁndings
and explore the genetic mechanisms.
Our analysis revealed that non- multidrug resistance was
associated with a high bacterial load of either a Beijing or
non-Beijing strain. Because acquisition of drug resistance
often leads to a reduction in virulence [32], it is possible that
a higher bacterial load will be needed for the patients to
become symptomatic and to seek medical help.
Our study has several limitations. First, although sensitive,
our Q-PCR method is likely to underestimate the prevalence
of mixed infection. Variable-number tandem repeat typing
with discriminatory loci would be an ideal approach. Discrimi-
nation between ‘ancient’ and ‘modern’ sublineages of Beijing
strains by NTF locus analysis [33] or RD deletion analysis
[6,34] is also important. Our Q-PCR method was unable to
detect mixed infection by two Beijing strains or two non-Beij-
ing strains. The use of only one isolate from each patient
could further underestimate mixed infection. Second, the
small number of patients with mixed infection in our study
limits the statistical power to detect other risk factors for
mixed infection, such as drug resistance and smear grading.
Further large-scale studies are necessary. Third, for patients
with mixed infection, drug susceptibility testing was not per-
formed separately for their Beijing and non-Beijing strains.
Furthermore, the serostatus of human immunodeﬁciency
virus was not routinely checked in this study. However, this
should not be a serious concern, as the incidence of human
immunodeﬁciency virus infection was 7.7 per 100 000 popula-
tion in Taiwan in 2008 and is currently decreasing [35].
Conclusion
We have developed a sensitive Q-PCR method to detect the
presence of Beijing and non-Beijing strains simultaneously in
smear-positive sputum samples and culture-positive liquid
medium samples. Patients who are under 25 years old and
have cavities on chest radiographs are prone to have mixed
infection by a Beijing and a non-Beijing strain, and the results
of drug susceptibility testing of their mycobacterial isolates
should be interpreted carefully. Beijing strains seem to be
more dominant than non-Beijing strains in patients with
mixed infection.
Author Contributions
J.-Y. Wang drafted the manuscript, and together with C.-Y.
Chiang, C.-J. Yu and L.-N. Lee, designed the study and inter-
preted the results. H.-L. Hsu and M.-C. Yu participated in
data collection and analysis. F.-L. Yu and M.-C. Yu performed
laboratory procedures. P.-C. Yang was the director responsi-
ble for general organization and instruction.
Acknowledgements
This study was supported by the National Science Council,
Taiwan (grant NSC 95-2314-B-002-089). We thank Fu-Chang
Hu, who works in the National Center of Excellence for
General Clinical Trial and Research in National Taiwan Uni-
versity Hospital, for performing the statistical analysis.
Transparency Declaration
All authors declare no conﬂict of interest of any nature.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Fig. S1. The primers and probes for detecting the Beijing
and non-Beijing strains of Mycobacterium tuberculosis in the
real-time quantitative polymerase chain reaction.
CMI Wang et al. Mixed infection in TB 1243
ª2010 The Authors
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 1239–1245
Fig. S2. The smoothing curve of the effect of age on the
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tive impact when age was less than 25 or greater than
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